HLA-A2 Antikörper
-
- Target
- HLA-A2
- Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Unkonjugiert
-
Applikation
- Flow Cytometry (FACS), Immunoprecipitation (IP), Immunohistochemistry (Frozen Sections) (IHC (fro))
- Produktmerkmale
- Purified IgG
- Aufreinigung
- Purified
- Klon
- BB7-2
- Isotyp
- IgG2b
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1.0 mg/mL
-
-
Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells." in: Stem cells (Dayton, Ohio), Vol. 24, Issue 2, pp. 221-9, (2006) (PubMed).
: "Induction of cytotoxic T-cell responses against immunoglobulin V region-derived peptides modified at human leukocyte antigen-A2 binding residues." in: Blood, Vol. 98, Issue 10, pp. 2999-3005, (2001) (PubMed).
: "
-
Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells." in: Stem cells (Dayton, Ohio), Vol. 24, Issue 2, pp. 221-9, (2006) (PubMed).
-
- Target
- HLA-A2
- Andere Bezeichnung
- HLA A2
- Substanzklasse
- Influenza Protein
- Gen-ID
- 3105
- UniProt
- P01892
-